Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, FARMACOCINÉTICA
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 24 abr. 2024.APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1002/jcph.758Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1002/jcph.758